Location History:
- Cardiff, GB (2004)
- Macclesfield, GB (2006 - 2015)
- Sodertalje, SE (2017)
- Edinburgh Midlothian, GB (2020)
Company Filing History:
3 out of 135 
2 out of 329 
1 out of 1,500 
Years Active: 2004-2020
Title: Paul Alfred Dickinson: Innovator in Medical Biomarkers and Compounds
Introduction
Paul Alfred Dickinson is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medical science, particularly in the development of biomarkers for infection detection and novel compounds. With a total of 6 patents, his work has the potential to impact neonatal care and pharmaceutical applications.
Latest Patents
One of Dickinson's latest patents is focused on molecular predictors of sepsis. Sepsis is a leading cause of morbidity and mortality in neonates worldwide. The invention addresses the challenges of diagnosing infections in neonates, who often present with varying symptoms. The lack of sensitive tests can lead to the unnecessary use of broad-spectrum antibiotics in infants without infections. This patent provides a series of patient-invariant biomarkers that can accurately predict bacterial infections, even in cases with negative blood-culture tests.
Another significant patent is related to hydrogen sulfate salt. This invention pertains to Compound 1 hydrogen sulfate salt and its various forms, including crystalline and amorphous states. The processes for preparing these compounds are also detailed in the patent, showcasing Dickinson's innovative approach to chemical formulations.
Career Highlights
Throughout his career, Paul Alfred Dickinson has worked with reputable organizations, including University College Cardiff Consultants Limited and Array Biopharma Inc. His experience in these companies has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Dickinson has collaborated with esteemed colleagues such as John A DeMattei and Tsung-Hsun Chuang. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Paul Alfred Dickinson's contributions to medical science through his patents demonstrate his commitment to innovation and improving healthcare outcomes. His work in developing biomarkers for sepsis and novel compounds highlights the importance of research in addressing critical health challenges.